Millennium Management
GLMD icon

Millennium Management’s Galmed Pharmaceuticals GLMD Stock Holding History

Millennium Management’s Portfolio GLMD Stock Details GLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,678
Closed -$12.5K – 6244
2023
Q3 		$12.5K Buy
1,678
+436
+35% +$5.78K ﹤0.01% 5731
2023
Q2 		$43.4K Buy
1,242
+511
+70% +$27.6K ﹤0.01% 5502
2023
Q1 		$56K Sell
731
-98
-12% -$10.5K ﹤0.01% 5593
2022
Q4 		$75K Buy
829
+569
+219% +$37.3K ﹤0.01% 5663
2022
Q3 		$15K Sell
260
-22
-8% -$1.88K ﹤0.01% 6535
2022
Q2 		$35K Buy
282
+222
+370% +$36.8K ﹤0.01% 6311
2022
Q1 		$17K Sell
60
-236
-80% -$66.9K ﹤0.01% 6666
2021
Q4 		$97K Buy
296
+224
+311% +$101K ﹤0.01% 6271
2021
Q3 		$36K Buy
+72
New +$37.8K ﹤0.01% 6621
2020
Q2 		– Sell
-131
Closed -$82K – 4307
2020
Q1 		$82K Buy
131
+48
+58% +$45.6K ﹤0.01% 3589
2019
Q4 		$87K Buy
+83
New +$71.3K ﹤0.01% 4044
2019
Q1 		– Sell
-115
Closed -$141K – 4085
2018
Q4 		$141K Sell
115
-1,719
-94% -$3M ﹤0.01% 3489
2018
Q3 		$4.48M Buy
1,834
+82
+5% +$192K 0.01% 1888
2018
Q2 		$3.75M Buy
1,752
+1,658
+1,764% +$2.4M ﹤0.01% 1989
2018
Q1 		$94K Buy
+94
New +$137K ﹤0.01% 3486

Other funds holding GLMD

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BCM
Bourgeon Capital Management Darien, Connecticut $679M AUM 50.89% 1-Year Est. Return

Millennium Management's GLMD Position: Q4 2023 in Review

Millennium Management sold out of Galmed Pharmaceuticals (GLMD) in Q4 2023, closing a stake of 1,678 shares — an estimated $12.5K sold.

Millennium Management first reported a position in GLMD in Q1 2018 and held it in 15 quarters. The position peaked at $4.48M in Q3 2018. 13 funds tracked by Wall St. Rank hold GLMD as of Q4 2023.

  • Millennium Management reported no remaining Galmed Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Millennium Management sold 1,678 Galmed Pharmaceuticals shares in Q4 2023, an estimated $12.5K.
  • Millennium Management first reported a position in Galmed Pharmaceuticals in Q1 2018 and held it in 15 quarters.
  • Millennium Management's Galmed Pharmaceuticals position peaked at $4.48M in Q3 2018.
  • 13 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.